Brain tumors can come about because of a number of reasons, if you were to speak to one person after another. However, the truth of the matter is that none of them have solid proof, meaning that it's difficult to pinpoint what the exact cause might be. Can a mutated gene come into play, though, for the sake of bringing greater attention to the tumors in question? After looking over a report on the matter, it seems like this element holds much in the way of importance.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
This mutated gene deserves to be focused on, especially when given the specifics behind it. The gene in question has been given the name of BRAF and it is one that is seen in tumor samples known as papillary craniopharyngiomas. For those who do not know, these are the ones that are not seen so much in children but rather adults. With the presence of this gene in this tumor type, it should make matters easier for researchers who are seeking out the most optimal types of drugs to incorporate.
When talking about the craniopharyngiomas, I was surprised to see how impactful they could see, not to mention how prevalent. For those who do not know, a single BRAF gene can drive tumors like these to become as aggressive as they are. The fact that a simple mutation, as opposed to multiple, can drive these tumors is a point that can potentially aid in the study of brain tumors. This may also make it easier to pinpoint more effective remedies, as organizations like Voices against Brain Cancer can vouch for.
The simpler that a particular method is in the way of science, the easier it is for it to be approached. This goes for just about anything but I feel like it strongly applies to this type of cancer. There are so many details to consider with tumors that being able to focus on a particular aspect and figure out what can be done in order to best target it is for the best. Hopefully this will be the case in the long run as mutated genes are given more focus in the medical field.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
This mutated gene deserves to be focused on, especially when given the specifics behind it. The gene in question has been given the name of BRAF and it is one that is seen in tumor samples known as papillary craniopharyngiomas. For those who do not know, these are the ones that are not seen so much in children but rather adults. With the presence of this gene in this tumor type, it should make matters easier for researchers who are seeking out the most optimal types of drugs to incorporate.
When talking about the craniopharyngiomas, I was surprised to see how impactful they could see, not to mention how prevalent. For those who do not know, a single BRAF gene can drive tumors like these to become as aggressive as they are. The fact that a simple mutation, as opposed to multiple, can drive these tumors is a point that can potentially aid in the study of brain tumors. This may also make it easier to pinpoint more effective remedies, as organizations like Voices against Brain Cancer can vouch for.
The simpler that a particular method is in the way of science, the easier it is for it to be approached. This goes for just about anything but I feel like it strongly applies to this type of cancer. There are so many details to consider with tumors that being able to focus on a particular aspect and figure out what can be done in order to best target it is for the best. Hopefully this will be the case in the long run as mutated genes are given more focus in the medical field.
About the Author:
For more information about brain tumors, please visit Voices against Brain Cancer for details.
No comments:
Post a Comment